| Code | 3344D | ||||||||||
| MA number | 44/0004/20-S | ||||||||||
| Product Form: | cps mol 4x20 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 23.01.2020 |
| SPC: |
SPC_Vinorelbine Glenmark 20 mg_05.2023.pdf
|
| PIL: |
PIL_Vinorelbine Glenmark 20 mg_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 11.01.2024 |
